Tuberculosis and Respiratory Diseases

The Korean Academy of Tuberculosis and Respiratory Diseases (대한결핵및호흡기학회)
권호 표지

Clinical Year in Review of COPD for Pulmonary Physicians

호흡기내과의사를 위한 만성폐쇄성폐질환(COPD) 리뷰

  • Oh, Yeon-Mok (Department of Pulmonary and Critical Care Medicine, Asan Medical Center, University of Ulsan College of Medicne)
  • 오연목 (울산대학교 의과대학 서울아산병원 호흡기내과)
  • Published : 2008.06.30
Download PDF
⟨ Previous Next ⟩

Abstract

Keywords

References

  1. Korea National Statistical Office, Republic of Korea [Internet]. Daejeon: Korea National Statistical Office; c1996- [cited 2008 Mar]. Available from: http://www. nso.go.kr
  2. Kim DS, Kim YS, Jung KS, Chang JH, Lim CM, Lee JH, et al. Prevalence of chronic obstructive pulmonary disease in Korea: a population-based spirometry survey. Am J Respir Crit Care Med 2005;172:842-7 https://doi.org/10.1164/rccm.200502-259OC
  3. Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJ. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet 2006;367:1747-57 https://doi.org/10.1016/S0140-6736(06)68770-9
  4. Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist SA, Calverley P, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2007;176:532-55 https://doi.org/10.1164/rccm.200703-456SO
  5. PubMed [Internet]. Bethesda (MD): National Library of Medicine (US). [1950] - [cited 2008 Mar]. Available from: http://www.ncbi.nlm.nih.gov/sites/entrez
  6. Mannino DM, Sonia Buist A, Vollmer WM. Chronic obstructive pulmonary disease in the older adult: what defines abnormal lung function? Thorax 2007;62:237-41 https://doi.org/10.1136/thx.2006.068379
  7. Aaron SD, Vandemheen KL, Fergusson D, Maltais F, Bourbeau J, Goldstein R, et al. Tiotropium in combination with placebo, salmeterol, or fluticasone-salmeterol for treatment of chronic obstructive pulmonary disease: a randomized trial. Ann Intern Med 2007;146:545-55 https://doi.org/10.1001/archinte.146.3.545
  8. Wedzicha JA, Calverley PM, Seemungal TA, Hagan G, Ansari Z, Stockley RA. The prevention of chronic obstructive pulmonary disease exacerbations by salmeterol/ fluticasone propionate or tiotropium bromide. Am J Respir Crit Care Med 2008;177:19-26 https://doi.org/10.1164/rccm.200707-973OC
  9. Calverley PM, Sanchez-Toril F, McIvor A, Teichmann P, Bredenbroeker D, Fabbri LM. Effect of 1-year treatment with roflumilast in severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2007;176: 154-61 https://doi.org/10.1164/rccm.200610-1563OC
  10. Osman LM, Douglas JG, Garden C, Reglitz K, Lyon J, Gordon S, et al. Indoor air quality in homes of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2007;176:465-72 https://doi.org/10.1164/rccm.200605-589OC
  11. Dransfield MT, Rowe SM, Johnson JE, Bailey WC, Gerald LB. Use of beta blockers and the risk of death in hospitalised patients with acute exacerbations of COPD. Thorax 2008;63:301-5 https://doi.org/10.1136/thx.2007.081893